Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Wheeling, West Virginia 25 trials found
New Search
Filter
Trial Phase
Study Type
ATEMPT 2.0: Adjuvant T-DM1 vs TH
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Testicular Tissue Cryopreservation for Fertility Preservation
NAINTERVENTIONAL Pittsburgh, Pennsylvania
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Fear of Recurrence and Stopping Immunotherapy
NAINTERVENTIONAL Pittsburgh, Pennsylvania
RECRUITING
Converting HR+ Breast Cancer Into an Individualized Vaccine
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NAINTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
NAINTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
N/AOBSERVATIONAL Pittsburgh, Pennsylvania
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
PHASE2, PHASE3INTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Stanford, California +4 more
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
NAINTERVENTIONAL Pittsburgh, Pennsylvania
RECRUITING
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
PHASE3INTERVENTIONAL La Jolla, California +4 more
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Detection of Genetic Markers of Lung Cancer
N/AOBSERVATIONAL Pittsburgh, Pennsylvania
RECRUITING
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type